Register now to learn about a new option for relapsed or refractory follicular lymphoma

General Discussions

Spinal Cord Ependymoma in the Prime of Life

By Laura Bruck
General Discussions - Discussions
23 replies
Eric Kratky

Eric Kratky

In January 2007, Erik Kratky was 21 and pursuing his undergraduate degree when he experienced bilateral leg weakness. Magnetic resonance imaging (MRI) revealed multiple spinal cord lesions in the T10 region and, after surgical resection, Erik was diagnosed with low-grade (II) spinal cord ependymoma.

He did well for 2 years and went on to graduate college, but in November 2009, he experienced lower-extremity weakness requiring confinement to a wheelchair. Imaging revealed tumor recurrence at the original site, as well as new tumor growth at T5, T6, and the upper level of T7, along with cord compression. T5/T6/T7 and T9/T10/T11 laminectomy was performed with resection of intradural extramedullary tumor, and pathology again revealed grade II disease.

Erik failed to improve postoperatively, and imaging revealed another recurrence, continued cord compression, and new tumor growth in the lumbar region (L1 and L4), consistent with dropped metastasis. He underwent resection of tumor in T9 through T12, and the ependymoma was upgraded to III-IV, with pathology suggestive of highly aggressive disease.

The following month, Erik was referred to the Cleveland Clinic. He underwent 4 1/2 weeks of whole-brain and spine radiation (5 days/week; 20 treatments with a planned boost), along with a total of three infusions of bevacizumab (Avastin) administered once every other week to help manage spinal cord edema and reduce further loss of leg function.

Erik did well for about 1 year, completing his graduate studies, teaching college-level math, and, with the help of physical and occupational therapy, walking with a walker. An MRI in June 2011 revealed diffuse progression of tumor in the lumbar region, and Erik began one 28-day cycle of oral lapatinib (INN; daily) and oral temozolomide (Temodar; days 1-7, repeated on days 15-21).

During a July hospitalization for a pain crisis, scanning demonstrated tumor progression in the cauda equina with spinal cord nerve irritation. Erik was discharged after single-dose emergent radiation and treatment with dexamethasone (Decadron), but within 1 month, repeat imaging demonstrated continued interval progression, necessitating a rethinking of options.

Erik was put back on intravenous (IV) bevacizumab (every 2 weeks), and a carboplatin (Paraplatin) infusion was added every 4 weeks. The carboplatin was discontinued in May 2012 due to myelosuppression, and today Erik remains on twicemonthly infusions of bevacizumab, which he tolerates well. While recent imaging shows an absence of tumor growth, Erik has sustained significant injury to his spinal cord and is currently confined to a wheelchair.

Treatment Considerations

Dr. Tanya Tekautz

Tanya Tekautz, MD

Because ependymoma is not especially chemotherapy- sensitive, and residual malignant cells are likely after resection, tumor resection followed by radiotherapy is considered the most effective treatment for preventing recurrence. Tanya Tekautz, MD, oncologist at the Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and director of the Pediatric and Young Adult Brain Tumor Program, explains that despite the absence of brain metastasis, irradiation of Erik’s spine and brain was considered the standard of care in light of the likelihood of metastasis of small cancer cells not seen on imaging.

Burkhardt Center nurse clinician Mary Murphy, RN, BSN, notes that Erik tolerated the bevacizumab relatively well, and didn’t develop serious adverse effects (eg, brain hemorrhage, unilateral lower-extremity thrombi) despite his increased risk for clotting due to being nonambulatory. “We watch carefully for signs of brain hemorrhage, such as garbled speech and other cognitive deficits,” says Murphy, “and monitor the lower extremities for swelling, redness, and pain.” Because some of these symptoms can be insidious, Tekautz sees patients at every chemotherapy treatment, rather than every 2 months after scanning. Eric recalls the radiation-related esophagitis as the most difficult of the adverse effects he endured.

During Erik’s June 2011 disease progression, oral chemotherapy allowed him to be up and around to the extent possible. But with limited options after the 2012 progression, the change was made to IV bevacizumab and carboplatin, based primarily on data from small studies showing that the combination can help to control or slow tumor growth in ependymoma patients previously treated with surgery and radiation. “As was the case with Erik, carboplatin can cause severe myelosuppression. It also can cause renal toxicity, increased risk of infection, nausea, and fatigue, requiring frequent clinic assessment and monitoring with twice-monthly labs,” says Murphy.

Mary Murphy

Mary Murphy, RN, BSN

It was at this time, at age 25, that Erik was transferred from pediatric to adult care.

Moving from Pediatric to Adult Care

“Aging out” of the pediatric population and transitioning to adult care can pose unique challenges. For Erik, who had developed strong attachments to his pediatric nurses, the change was a difficult one. “The adult care staff is great, but the pediatric environment was incredibly nurturing for me and my parents,” says Eric.

For Eric, the balance between the desire for independence and the need for compassionate care has been difficult to achieve, especially in light of his disability, which necessitated a return to his parents’ home just as his adult life had begun. “It’s the disability that’s hardest to deal with. I had to relearn how to do everything,” he says. Erik credits his family, Tekautz, Murphy, and all of his nurses for helping him to maintain a positive attitude.

Each time it progresses, Erik’s disease becomes more difficult to treat. While reluctant to make any long-term predictions, Murphy and Tekautz note that the current goal is to control any tumor growth for as long as possible in a patient they describe as “magic to everyone who knows him.”
Laura Bruck is a freelance writer and editor based in Cleveland, Ohio. She has specialized in healthcare reporting since 1987.
By Danny374
Oct 05, 2020 12:59:55 am
Spinal cord injury can totally damage the walking power. It can lead to permanent walking disability. But there are many options to move one plate to another for them. They can use a wheelchair, mobility walkers. It will be very helpful to them. They won't think of themselves as a burden.
By JohnCooper
Oct 13, 2020 2:09:44 am
These problems are not more aggressive, and also can be treated. --------------------- Best Hosting UK
By lifetime
Oct 13, 2020 11:40:06 am
Your work is very good and I appreciate you and hopping for some more informative posts general contractor
By lifetime
Oct 13, 2020 11:40:53 am
Very interesting blog. Alot of blogs I see these days don't really provide anything that I'm interested in, but I'm most definately interested in this one. Just thought that I would post and let you know. videographers near me
By lifetime
Oct 18, 2020 11:10:00 am
Thumbs up guys your doing a really good job. Bagosihs
By Anony
Oct 19, 2020 7:27:56 am
very informative article on spinal cord injury I just happened to read while searching for cheap essay writing service UK to get my college assignment done professionaly as I have to concentrate on my newly joined job.Thanks for sharing your story and I pray may your pains be eased.
By Cindy33
Oct 21, 2020 12:47:28 am
Pretty great post. I just stumbled upon your weblog and wanted to say that Ive really enjoyed surfing around your blog posts. In any case I will be subscribing for your rss feed and I hope you write again very soon! telegraph
By ...
Oct 21, 2020 4:27:56 am;Amount=Month;NavType=Absolute;Type=Block&CalendarName=nathandrake&Date=2020/09/30&ID=66081639&Source=*****
By lifetime
Oct 23, 2020 9:30:34 am
Interesting post. I Have Been wondering about this issue, so thanks for posting. Pretty cool post.It 's really very nice and Useful post.Thanks Click Here
By lifetime
Oct 23, 2020 9:32:57 am
It is perfect time to make some plans for the future and it is time to be happy. Ive read this post and if I could I desire to suggest you few interesting things or tips. Perhaps you could write next articles referring to this article. I want to read more things about it! Click Here
By lifetime
Oct 23, 2020 9:36:27 am
I am hoping the same best effort from you in the future as well. In fact your creative writing skills has inspired me. Click Here
By lifetime
Oct 23, 2020 9:39:00 am
I have bookmarked your website because this site contains valuable information in it. I am really happy with articles quality and presentation. Thanks a lot for keeping great stuff. I am very much thankful for this site. Click Here
By lifetime
Oct 23, 2020 9:41:48 am
Really impressed! Everything is very open and very clear clarification of issues. It contains truly facts. Your website is very valuable. Thanks for sharing. Click Here
By lifetime
Oct 23, 2020 9:44:07 am
so happy to find good place to many here in the post, the writing is just great, thanks for the post. Click Here
By lifetime
Oct 23, 2020 9:46:14 am
I think about it is most required for making more on this get engaged Click Here
By lifetime
Oct 23, 2020 9:48:50 am
Your blog provided us with valuable information to work with. Each & every tips of your post are awesome. Thanks a lot for sharing. Keep blogging, Click Here
By lifetime
Oct 23, 2020 9:51:05 am
The web site is lovingly serviced and saved as much as date. So it should be, thanks for sharing this with us. Click Here
By lifetime
Oct 23, 2020 9:53:21 am
I really appreciate the kind of topics you post here. Thanks for sharing us a great information that is actually helpful. Good day! Click Here
By lifetime
Oct 23, 2020 9:55:41 am
Wow what a Great Information about World Day its exceptionally pleasant educational post. a debt of gratitude is in order for the post. Click Here
By lifetime
Oct 23, 2020 10:08:01 am
I am very enjoyed for this blog. Its an informative topic. It help me very much to solve some problems. Its opportunity are so fantastic and working style so speedy. Click Here
By lifetime
Oct 23, 2020 10:10:29 am
This is also a very good post which I really enjoyed reading. It is not every day that I have the possibility to see something like this.. Click Here
By lifetime
Oct 23, 2020 10:12:53 am
I see the greatest contents on your blog and I extremely love reading them. Click Here
By lifetime
Oct 23, 2020 10:15:23 am
Great post! I am actually getting ready to across this information, is very helpful my friend. Also great blog here with all of the valuable information you have. Keep up the good work you are doing here. Click Here
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.